Orotracheal intubation in emergency medicine is a vital procedure for ensuring adequate oxygenation and ventilation in patients with respiratory distress or in shock. However, this procedure exposes patients to complications such as pneumonia. In the matter of fact, the urgency of the procedure means that it is not possible to wait until the patient's stomach is empty. Pneumonia significantly increase patient morbidity and mortality. Therapeutic management must be early and appropriate to improve the patient's prognosis. The aim of this study is to compare the rate of pneumonia occurring in patients intubated in emergency situations with that in patients intubated in non-emergency situations in all 2024. Health data will only collected from patient's medical records.
Study Type
OBSERVATIONAL
Enrollment
600
CH Aurillac
Aurillac, France
CHU de Clermont-Ferrand, Clermont-Ferrand
Clermont-Ferrand, France
CH du Puy en Velay
Le Puy-en-Velay, France
CH de Montluçon
Montluçon, France
CH de Moulins
Moulins, France
CH de Vichy
Vichy, France
Pneumonia rate in 48 hours after the start of orotracheal intubation.
Rate of pneumonia occuring within 48 hours of the start of orotracheal intubation.
Time frame: Hour 48
Pneumonia rate occuring 48 hours after the start of orotracheal intubation.
Rate of pneumonia occuring more than 48 hours after the start of orotracheal intubation.
Time frame: 3 months
Duration of mechanical ventilation
Duration of mechanical ventilation
Time frame: Up to the end of mechanical ventilation (assessed up to 1 month)
Duration of stay in intensive care
Duration of stay in intensive care
Time frame: Up to intensive care discharge (assessed up to 1 month)
Duration of hospital stay
Duration of hospital stay
Time frame: Up to hospital discharge (assessed up to 3 months)
Mortality rate
Mortality rate
Time frame: Inclusion + 1 year
Type of bacteria responsible for pneumonia
The bacterial species responsible for pneumonia will be identified using biological samples (blood, urine, bronchial secretions) taken from patients in both groups. The identification of bacterial species will be carried out in the laboratory.
Time frame: The day of the diagnosis of pneumonia (assessed up to 1 month)
Type of antibiotic administered for pneumonia
Type of antibiotic administered for pneumonia in each group
Time frame: Up to the last day of antibiotic treatment (assessed up to 3 months)
Antibiotic doses administered for pneumonia
Comparison of antibiotic doses in g or mg administered in each group
Time frame: Up to the last day of antibiotic treatment (assessed up to 3 months)
Duration of antibiotic treament for pneumonia
Duration of antibiotic treament for pneumonia in each group
Time frame: Up to the last day of antibiotic treatment (assessed up to 3 months)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.